Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
0%
OVERLAP
BY WEIGHT
0
# OF OVERLAPPING
HOLDINGS
IDNA
44
HOLDINGS
0%
ALSO IN XDNA
XDNA
3
HOLDINGS
nan%
ALSO IN IDNA
SECTOR DRIFT (IDNA minus XDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IDNA |
Weight in XDNA |
Overlap | |
|---|---|---|---|---|
IDNA Overweight Relative to XDNA
 |
GENMAB A/S | 5.0% |
 |
INCYTE CORP | 4.7% |
|
REGENERON PHARMACEUTICALS | 4.5% |
|
REVOLUTION MEDICINES, INC. | 4.5% |
|
ARCELLX, INC. | 4.4% |
 |
ASTRAZENECA PLC | 4.3% |
|
MERCK & CO. INC. | 4.1% |
 |
TAKEDA PHARMACEUTICAL CO LTD | 4.0% |
 |
ROCHE HOLDING LTD | 4.0% |
|
GSK PLC | 3.9% |
IDNA Underweight Relative to XDNA
|
INTELLIA THERAPEUTICS, INC. | 0.1% |
|
BEAM THERAPEUTICS, INC. | 0.2% |
|
LIGAND PHARMACEUTICALS-CL B | 0.3% |
|
ONO PHARMACEUTICAL CO LTD | 0.4% |
|
CRISPR THERAPEUTICS AG | 0.4% |
|
IMMUNITYBIO INC | 0.5% |
|
PACIFIC BIOSCIENCES OF CALIF | 0.7% |
 |
ALCOBRA LTD | 1.0% |
|
ORIC PHARMACEUTICALS INC | 1.0% |
|
VIR BIOTECHNOLOGY, INC. | 1.0% |